|
1
|
Kitajima K, Shiba H, Nojiri T, Uwagawa T,
Ishida Y, Ichiba N and Yanaga K: Intrahepatic cholangiocarcinoma
mimicking hepatic inflammatory pseudotumor. J Gastrointest Surg.
11:398–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Adam SZ, Parthasarathy S and Miller FH:
Intrahepatic cholangiocarcinomas mimicking other lesions. Abdom
Imaging. 40:2345–2354. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Walter D, Döring C, Feldhahn M, Battke F,
Hartmann S, Winkelmann R, Schneider M, Bankov K, Schnitzbauer A,
Zeuzem S, et al: Intratumoral heterogeneity of intrahepatic
cholangiocarcinoma. Oncotarget. 8:14957–14968. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kozaka K, Matsui O, Kobayashi S, Koda W,
Minami T, Kitao A, Inoue D, Yoneda N, Yoshida K, Toshima F, et al:
Dynamic CT findings of cholangiolocellular carcinoma: Correlation
with angiography-assisted CT and histopathology. Abdom Radiol (NY).
42:861–869. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tasch JJ and Dube N: An unusual
presentation of advanced intrahepatic cholangiocarcinoma: When
biopsy results fail. Am J Case Rep. 19:35–40. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishii N, Suzuki H, Tsukagoshi M, Watanabe
A, Kubo N, Araki K, Wada S and Kuwano H: Giant cholangiolocellular
carcinoma with early recurrence that was difficult to distinguish
from cholangiocellular carcinoma: Report of a case. Int Surg.
100:1111–1116. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bragazzi MC, Ridola L, Safarikia S, Matteo
SD, Costantini D, Nevi L and Cardinale V: New insights into
cholangiocarcinoma: Multiple stems and related cell lineages of
origin. Ann Gastroenterol. 31:42–55. 2018.PubMed/NCBI
|
|
8
|
Schlageter M, Terracciano LM, D'Angelo S
and Sorrentino P: Histopathology of hepatocellular carcinoma. World
J Gastroenterol. 20:15955–15964. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vijgen S, Terris B and Rubbia-Brandt L:
Pathology of intrahepatic cholangiocarcinoma. Hepatobiliary Surg
Nutr. 6:22–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM Classification of Malignant Tumours. 8th edition.
Wiley-Blackwell; Oxford: pp. 2722017
|
|
11
|
Nakanuma Y, Harada K, Ishikawa A, Zen Y
and Sasaki M: Anatomic and molecular pathology of intrahepatic
cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 10:265–281.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khan SA, Thomas HC, Davidson BR and
Taylor-Robinson SD: Cholangiocarcinoma. Lancet. 366:1303–1314.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakanuma Y, Sato Y, Harada K, Sasaki M, Xu
J and Ikeda H: Pathological classification of intrahepatic
cholangiocarcinoma based on a new concept. World J Hepatol.
2:419–427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sakamoto Y, Kokudo N, Matsuyama Y,
Sakamoto M, Izumi N, Kadoya M, Kaneko S, Ku Y, Kudo M, Takayama T,
et al: Proposal of a new staging system for intrahepatic
cholangiocarcinoma: Analysis of surgical patients from a nationwide
survey of the Liver Cancer Study Group of Japan. Cancer. 122:61–70.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Konstantinidis IT, Koerkamp Groot B, Do
RK, Gönen M, Fong Y, Allen PJ, D'Angelica MI, Kingham TP, DeMatteo
RP, Klimstra DS, et al: Unresectable intrahepatic
cholangiocarcinoma: Systemic plus hepatic arterial infusion
chemotherapy is associated with longer survival in comparison with
systemic chemotherapy alone. Cancer. 122:758–765. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Buettner S, van Vugt JL, IJzermans JN and
Koerkamp Groot B: Intrahepatic cholangiocarcinoma: Current
perspectives. Onco Targets Ther. 10:1131–1142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malhi H and Gores GJ: Cholangiocarcinoma:
Modern advances in understanding a deadly old disease. J Hepatol.
45:856–867. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doherty B, Nambudiri VE and Palmer WC:
Update on the diagnosis and treatment of cholangiocarcinoma. Curr
Gastroenterol Rep. 19:22017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brandi G, Farioli A, Astolfi A, Biasco G
and Tavolari S: Genetic heterogeneity in cholangiocarcinoma: A
major challenge for targeted therapies. Oncotarget. 6:14744–14753.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ariizumi S, Kotera Y, Katagiri S, Nakano
M, Nakanuma Y, Saito A and Yamamoto M: Long-term survival of
patients with cholangiolocellular carcinoma after curative
hepatectomy. Ann Surg Oncol. 21 Suppl 3:S451–S458. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu L, Wang W, Chen B, Xie W, Zhang Y,
Zhang Z, Li Q, Li S, Hua Y, Shen S and Peng B: Combined
hepatocellular and cholangiocarcinoma-WHO classi cation-based
analysis of long-term prognosis after surgery. Int J Clin Exp
Pathol. 10:6601–6612. 2017.
|
|
22
|
Kudo M, Kitano M, Sakurai T and Nishida N:
General rules for the clinical and pathological study of primary
liver cancer, nationwide follow-up survey and clinical practice
guidelines: The outstanding achievements of the Liver Cancer Study
Group of Japan. Dig Dis. 33:765–770. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yano Y, Yamamoto J, Kosuge T, Sakamoto Y,
Yamasaki S, Shimada K, Ojima H, Sakamoto M, Takayama T and Makuuchi
M: Combined hepatocellular and cholangiocarcinoma-a
clinicopathologic study of 26 resected cases. Jpn J Clin Oncol.
33:283–287. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Komuta M, Spee B, Vander Borght S, De Vos
R, Verslype C, Aerts R, Yano H, Suzuki T, Matsuda M, Fujii H, et
al: Clinicopathological study on cholangiolocellular carcinoma
suggesting hepatic progenitor cell origin. Hepatology.
47:1544–1556. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoh T, Kato T, Hirohata Y, Nakamura Y,
Nakayama H and Okamura R: Cholangiolocellular carcinoma with rapid
progression initially showing abnormally elevated serum
alfa-fetoprotein. Clin J Gastroenterol. 9:257–260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoshino H, Ohta M, Ito M, Uchimura K,
Sakai Y, Uehara T, Low S, Fukushima M and Kobayashi M: Apical
membrane expression of distinct sulfated glycans represents a novel
marker of cholangiolocellular carcinoma. Lab Invest. 96:1246–1255.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Akabane S, Ban T, Kouriki S, Tanemura H,
Nakazaki H, Nakano M and Shinozaki N: Successful surgical resection
of ruptured cholangiolocellular carcinoma: A rare case of a primary
hepatic tumor. World J Hepatol. 9:752–756. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ishii N, Araki K, Yamanaka T, Handa T,
Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Aishima S, Kuwano H
and Shirabe K: Small cholangiolocellular carcinoma that was
difficult to distinguish from cholangiocellular carcinoma: A case
report. Surg Case Rep. 3:1032017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Komuta M, Govaere O, Vandecaveye V, Akiba
J, Van Steenbergen W, Verslype C, Laleman W, Pirenne J, Aerts R,
Yano H, et al: Histological diversity in cholangiocellular
carcinoma reflects the different cholangiocyte phenotypes.
Hepatology. 55:1876–1888. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Motosugi U, Ichikawa T, Nakajima H, Araki
T, Matsuda M, Suzuki T, Fujii H, Nakazawa T and Yamaguchi H:
Cholangiolocellular carcinoma of the liver-imaging findings. J
Comput Assist Tomogr. 33:682–688. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cardinale V, Carpino G, Reid L, Gaudio E
and Alvaro D: Multiple cells of origin in cholangiocarcinoma
underlie biological, epidemiological and clinical heterogeneity.
World J Gastrointest Oncol. 4:94–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Patel T: New insights into the molecular
pathogenesis of intrahepatic cholangiocarcinoma. J Gastroenterol.
49:165–172. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Raggi C, Invernizzi P and Andersen JB:
Impact of microenvironment and stem-like plasticity in
cholangiocarcinoma: Molecular networks and biological concepts. J
Hepatol. 62:198–207. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sadot E, Simpson AL, Do RK, Gonen M, Shia
J, Allen PJ, D'Angelica MI, DeMatteo RP, Kingham TP and Jarnagin
WR: Cholangiocarcinoma: Correlation between molecular profiling and
imaging phenotypes. PLoS One. 10:e01329532015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shimada K, Sano T, Nara S, Esaki M,
Sakamoto Y, Kosuge T and Ojima H: Therapeutic value of lymph node
dissection during hepatectomy in patients with intrahepatic
cholangiocellular carcinoma with negative lymph node involvement.
Surgery. 145:411–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Adachi T and Eguchi S: Lymph node
dissection for intrahepatic cholangiocarcinoma: A critical review
of the literature to date. J Hepatobiliary Pancreat Sci.
21:162–168. 2014. View Article : Google Scholar : PubMed/NCBI
|
